Introduction: Chronic diseases have become a major public health problem. Chronic diseases are a leading cause of morbidity and mortality in India and other low and middle-income countries. Kidney damage is defined as "pathologic abnormalities of marker of damage, including abnormalities in blood or urine tests or imaging studies." Aims and Objective: This study aims to estimate C-reactive protein, urea, creatnine levels, which is an indicator of inflammation and prognonosis in CKD because this will help the medical staff for proper management with less morbidity and mortality. Methods of Assay: Estimation of serum C-reactive protein, serum urea, and creatinine will be assessd by using commercially reagents and kits. Result: CKD is more common in old age group or chance of that majority of our patients where male and in the age group of 10-60 getting CKD increases as the age of person increases. The male constituted about 60% of the total. While female patients constituted about 40% of total patients. Conclusion: It is concluded that maximum number of chronic kidney diseases occur in the man than women. Age prone to kidney diseases is 41-50 years. CKD is directly proportional to age.
Introduction
Chronic diseases have become a major public health problem. Chronic diseases are a leading cause of morbidity and mortality in India and other low-and middle-income countries. The chronic diseases account for 60% of all deaths worldwide. Eighty percentage of chronic disease deaths worldwide occur in low and middle-income countries. 1 CKD is defined as kidney damage or glomerular filtration rate (GFR) <60 mol/min/1.73 m2 for 3 months or more, irrespective of cause. 2 Kidney damage is defined as "pathologic abnormalities or markers of damage, including abnormalities in blood or urine tests or imaging studies." 3 CKD can be detected via simple biochemical tests including a creatinine-based estimate of the glomerular filtration rate (GFR). Serum C Reactive protein level is elevated in patients with chronic kidney disease. 4-5 Urea, and creatinine concentrations of middle and late stage chronic kidney disease patients were obviously higher than those of healthy people and early stage chronic kidney disease patients. 6, 7 In community based studies, the chronic kidney disease prevalence has been reported between 0.16% and 0.79%. The studies were designed to www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.155 detect stage -3 chronic kidney disease or worse and the renal prevalence of chronic kidney disease is higher than the reported number. 8, 9, 10 The end stage renal disease incidence has been reported to be 160 to 232 (PMP). The projected end stage renal disease prevalence was 785 to 870 pmp. 11, 12, 13 There are different renal function parameters to indicate reduced kidney function. CKD typically increases with age and therefore there is increased risk in older adults. It is found that females are less prone to the risk of CKD. 14, 15 The declaration of World Kidney Day to be observed annually beginning in March 2006 sends a clear message to the public, government health officials, physicians, allied health professionals, patients, and families that 'CKD is common, harmful, and treatable' 16 The incidence of CKD increases with age. The annual incidence in middle aged is about 1%. Women have higher incidence of CKD but lower risk for kidney failure than men. African Americans have higher risk for kidney failure. 17, 18 So this study is designed to determine the following:- To estimate serum level of C-reactive protein, urea and cretnine in normal subjects.  To estimate serum serum level of Creactive protein, urea and creatnine level in CKD.  To compare serum level of C-reactive protein, urea and creatnine in CKD patients and normal subjects.
Methodology Study Place and Design
This study will be carried out in department of Biochemistry in collaborations with department of medicine, and department of microbiology of pacific medical college and hospital, Udaipur. It is observational case control study, will include 100 subjects. Out of 100 subjects, 50 patients of chronic kidney disease and another 50 normal subjects will be age and sex matched healthy volunteers as control group. The control group will be taken for patient's attendants, staff, and student and may be from private laboratories which conduct routine serum check up of healthy persons.
Investigations • Estimation of serum urea Principal
The quantitative estimation serum urea is done by semi-analyzer using enzymatic kit • Estimation of serum creatnine Principal The quantitative estimation serum urea is done by semi-analyzer using enzymatic kit • Estimation of serum C-reactive protein PrincipalSemi-quantitative analysis of CRP is done by Latex agglutination method.
Statically Analysis
Data will be entered on SPSS in the form of master chart. This data will be classified and analyzed as per aims and objectives. Quantitative data will be expressed in the form of Mean + SD .Infrence will be drawn with the use of appropriate test of significance. Table 1 shows that The mean serum Urea level was found to be 32.78±4.52 mg/dl in control subjects and The mean serum urea level was found to be 102.34±24.92 mg/dl in the patients of chronic kidney disease and p-value is <0.0001 and highly significant . Table 1 shows that The mean serum creatinine level was found to be 1.014±0.19 in control subjects and The mean serum creatinine level was found to be 10.64±2.56 mg/dl in patients of chronic kidney disease and p-value is <0.0001 and highly significant. This increase might be due to decreased excretion of creatinine by poor functioning of kidney. 
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